Quarterly report pursuant to Section 13 or 15(d)


Cover - shares
3 Months Ended
Mar. 31, 2024
May 10, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 001-13341  
Entity Registrant Name Titan Pharmaceuticals, Inc.  
Entity Central Index Key 0000910267  
Entity Tax Identification Number 94-3171940  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 400 Oyster Point Blvd.  
Entity Address, Address Line Two Suite 505  
Entity Address, City or Town South San Francisco  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94080  
City Area Code (650)  
Local Phone Number 244-4990  
Title of 12(b) Security Common Stock, par value $0.001  
Trading Symbol TTNP  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   914,234